The role, mechanism, and application of RNA methyltransferase METTL14 in gastrointestinal cancer

B Shi, WW Liu, K Yang, GM Jiang, H Wang - Molecular cancer, 2022 - Springer
Gastrointestinal cancer is the most common human malignancy characterized by high
lethality and poor prognosis. Emerging evidences indicate that N6-methyladenosine (m6A) …

N6-methyladenosine-modified circular RNA QSOX1 promotes colorectal cancer resistance to anti-CTLA-4 therapy through induction of intratumoral regulatory T cells

Z Liu, N Zheng, J Li, C Li, D Zheng, X Jiang, X Ge… - Drug Resistance …, 2022 - Elsevier
Background Colorectal cancer (CRC) is the 3rd most common cancer worldwide. CircRNAs
are promising novel biomarkers for CRC. T regulatory (Treg) cells express the immune …

[HTML][HTML] N6-methyladenosine-induced circ1662 promotes metastasis of colorectal cancer by accelerating YAP1 nuclear localization

C Chen, W Yuan, Q Zhou, B Shao, Y Guo, W Wang… - Theranostics, 2021 - ncbi.nlm.nih.gov
Tumor metastasis is the leading cause of death in patients with colorectal cancer (CRC).
Circular RNAs (circRNAs) have been shown to be involved in cancer progression. However …

m6A modification on the fate of colorectal cancer: functions and mechanisms of cell proliferation and tumorigenesis

X Jiang, Z Jin, Y Yang, X Zheng, S Chen… - Frontiers in …, 2023 - frontiersin.org
N6-methyladenosine (m6A) is the most pervasive RNA modification in eukaryotic cells. The
dynamic and reversible m6A modification of RNA plays a critical role in the occurrence and …

[HTML][HTML] Saikosaponin D exhibits anti-leukemic activity by targeting FTO/m6A signaling

K Sun, Y Du, Y Hou, M Zhao, J Li, Y Du, L Zhang… - Theranostics, 2021 - ncbi.nlm.nih.gov
Purpose: The implementation of targeted therapies for acute myeloid leukemia (AML) has
been challenging. Fat mass and obesity associated protein (FTO), an mRNA N 6 …

M6AREG: m6A-centered regulation of disease development and drug response

S Liu, L Chen, Y Zhang, Y Zhou, Y He… - Nucleic Acids …, 2023 - academic.oup.com
As the most prevalent internal modification in eukaryotic RNAs, N 6-methyladenosine (m6A)
has been discovered to play an essential role in cellular proliferation, metabolic …

N6‐methyladenosine demethylase ALKBH5 suppresses colorectal cancer progression potentially by decreasing PHF20 mRNA methylation

Z Zhang, L Wang, L Zhao, Q Wang… - Clinical and …, 2022 - Wiley Online Library
Background As the most widespread mRNAs modification, N6‐methyladenosine (m6A) is
dynamically and reversibly modulated by methyltransferases and demethylases. ALKBH5 is …

[HTML][HTML] Insights into the mechanism underlying crystalline silica-induced pulmonary fibrosis via transcriptome-wide m6A methylation profile

Y Zhang, P Gu, Y Xie, L Fan, X You, S Yang… - Ecotoxicology and …, 2022 - Elsevier
Silicosis is one of the most severe interstitial lung fibrosis diseases worldwide, caused by
crystalline silica exposure. While the mechanisms and pathogenesis underlying silicosis …

Molecular characteristics, oncogenic roles, and relevant immune and pharmacogenomic features of EVA1B in colorectal cancer

B Ma, K Wang, Y Liang, Q Meng, Y Li - Frontiers in Immunology, 2022 - frontiersin.org
Objective EVA1B, a protein coding gene, is a critical paralog of EVA1A gene. Herein, our
study was conducted to investigate the role of EVA1B in colorectal cancer (CRC) …

[HTML][HTML] N6-methyladenosine (m6A) in pancreatic cancer: Regulatory mechanisms and future direction

J Li, F Wang, Y Liu, H Wang, B Ni - International Journal of …, 2021 - ncbi.nlm.nih.gov
Abstract N 6-methyladenosine (m 6 A), the most abundant RNA modification in eukaryotes,
plays a pivotal role in regulating many cellular and biological processes. Aberrant m 6 A …